Actionable news
All posts from Actionable news

Cramer Remix: Biggest surprise for Valeant's new CEO

Valeant Pharmaceuticals' new CEO Joseph Papa stands to receive over $67 million, but he insists he's not in it for the money.

"This is not about the money," Papa said in an interview with CNBC's Jim Cramer. "To me this is all about if I can play a small role in improving Valeant and [if] that has a beneficial impact on the entire pharmaceutical industry, I think I will have done something that is important."

According to published reports, Valeant will pay Papa $67.4 million in cash, options and restricted stock this year.

Valeant announced on April 25 that Papa would assume the role of chairman and CEO of the embattled company, to succeed Michael Pearson. Papa has more than 35 years in the pharmaceutical industry, including his most recent role as CEO of Perrigo.

"The biggest surprise and the reason that really got me, is I looked at their pipeline. Because to me, that is going to predict how a company is successful in the future. Are they going to grow organically or not," Papa said.

On Monday, Cramer watched as the stocks that were loved the most on Friday were suddenly loathed.

It all came down to new data that changed the opinions of the most influential investors on Wall Street.

U.S. employment data and Chinese trade figures were the proximate cause of Monday's mixed trading. When the Labor Department released non-farm payroll data on Friday, initially Cramer thinks the big buyers couldn't figure out what the data meant for the...